In New Report, FDA Advisors Echo Senator Hassan's Calls for FDA to Update its Opioid Labelling Policies as Overdose Deaths in NH Remain High
February 23, 2023
February 23, 2023
WASHINGTON, Feb. 23 (TNSrpt) -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
A recent report from The Ohio State University, commissioned by the Food and Drug Administration (FDA), echoes Senator Maggie Hassan's calls for the FDA to update its policies for labelling opioid prescriptions. The report comes as overdose deaths in New Hampshire remain high.
The new report underscored the lack of evidence for the long-term efficacy of prescription o . . .
A recent report from The Ohio State University, commissioned by the Food and Drug Administration (FDA), echoes Senator Maggie Hassan's calls for the FDA to update its policies for labelling opioid prescriptions. The report comes as overdose deaths in New Hampshire remain high.
The new report underscored the lack of evidence for the long-term efficacy of prescription o . . .